COEGIN — Coegin Pharma AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK45.97m
- SEK40.42m
Annual cashflow statement for Coegin Pharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | — | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -26.7 | -46.2 | -25.8 | -35.2 | -28 |
| Non-Cash Items | 23.7 | 37.2 | 0.009 | 2.72 | 3.02 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -14.1 | 1.3 | 4.35 | -5.71 | 2.93 |
| Change in Accounts Receivable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -17.1 | -7.78 | -21.5 | -38.2 | -22 |
| Capital Expenditures | — | 0 | 0 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 22.4 | — | 0 | 12 | 0 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 22.4 | 0 | 0 | 12 | 0 |
| Financing Cash Flow Items | -3.66 | 6.92 | -2.56 | 4 | 0.925 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 9.95 | 23.9 | 29.3 | 4 | 23.8 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 15.3 | 14.9 | 9.01 | -21.8 | 1.73 |